Vanguard Global Advisers »

Relay Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $747k 75k 9.95

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Relay Therapeutics

Sb Investment Advisers
Commodore Capital
Casdin Capital
BlackRock
Perceptive Advisors
Vanguard Group
Bellevue Group
Vanguard Capital Management
State Street Corporation
Nextech Invest
TCG Crossover Management
Geode Capital Management
Balyasny Asset Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Relay Therapeutics